1. Home
  2. NOTV vs VNRX Comparison

NOTV vs VNRX Comparison

Compare NOTV & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.76

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
VNRX
Founded
1974
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
38.2M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NOTV
VNRX
Price
$0.76
$0.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$3.00
$3.17
AVG Volume (30 Days)
1.6M
2.8M
Earning Date
12-03-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$1,472,007.00
Revenue This Year
$6.26
$55.33
Revenue Next Year
$45.49
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
4.54
14.48
52 Week Low
$0.66
$0.27
52 Week High
$6.48
$0.94

Technical Indicators

Market Signals
Indicator
NOTV
VNRX
Relative Strength Index (RSI) 35.16 31.94
Support Level $0.79 $0.28
Resistance Level $0.86 $0.31
Average True Range (ATR) 0.07 0.03
MACD 0.01 0.00
Stochastic Oscillator 3.93 3.40

Price Performance

Historical Comparison
NOTV
VNRX

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: